Loading...

Mark Krailo, PhD

Title(s)Professor of Research Preventive Medicine
AddressChildren's Oncology Group
Health Sciences Campus
Monrovia CA 91016
Phone+1 323 442 8233
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    2000Ford Scholarship
    2000National Research Council Postgraduate Scholarship
    2000Ontario Graduate Scholarship
    2000University of Windsor Entrance Award
    2000Ontario Scholarship
    2000Board of Governor's Award, University of Windsor

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Developing and Using a Data Commons for Understanding the Molecular Characteristics of Germ Cell Tumors. Methods Mol Biol. 2021; 2195:263-275. Ci B, Lin SY, Yao B, Luo D, Xu L, Krailo M, Murray MJ, Amatruda JF, Frazier AL, Xie Y. PMID: 32852769.
      View in: PubMed   Mentions:    Fields:    
    2. Reply to S. Upadhyaya. J Clin Oncol. 2020 Jul 30; JCO2001573. Reddy AT, Krailo MD, Buxton AB, Strother DR, Huang A, Zhou T, Judkins AR, Burger PC, Pollack IF, Williams-Hughes C, Fouladi M, Ho B, Mazewski CM, Lewis VA, Vezina LG, Booth TN, Mahajan A. PMID: 32730180.
      View in: PubMed   Mentions:    Fields:    
    3. Information fraction estimation based on the number of events within the standard treatment regimen. Biom J. 2020 Jul 06. Dang HM, Alonzo T, Franklin M, Mack WJ, Krailo MD, Eckel SP. PMID: 32627859.
      View in: PubMed   Mentions:    Fields:    
    4. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231). Pediatr Blood Cancer. 2020 Jun 26; e28502. Jubran RF, Villablanca JG, Krailo M, Piao J, Huang L, Murphree AL, O'Brien J, Gombos D, Shields CL, Meadows A, Chintagumpala M. PMID: 32589362.
      View in: PubMed   Mentions:    Fields:    
    5. Development of a Data Model and Data Commons for Germ Cell Tumors. JCO Clin Cancer Inform. 2020 Jun; 4:555-566. Ci B, Yang DM, Krailo M, Xia C, Yao B, Luo D, Zhou Q, Xiao G, Xu L, Skapek SX, Murray MM, Amatruda JF, Klosterkemper L, Shaikh F, Faure-Conter C, Fresneau B, Volchenboum SL, Stoneham S, Lopes LF, Nicholson J, Frazier AL, Xie Y. PMID: 32568554.
      View in: PubMed   Mentions:    Fields:    
    6. The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database. Pediatr Blood Cancer. 2020 08; 67(8):e28350. Haeberle B, Rangaswami A, Krailo M, Czauderna P, Hiyama E, Maibach R, Lopez-Terrada D, Aronson DC, Alaggio R, Ansari M, Malogolowkin MH, Perilongo G, O'Neill AF, Trobaugh-Lotrario AD, Watanabe K, Schmid I, von Schweinitz D, Ranganathan S, Yoshimura K, Hishiki T, Tanaka Y, Piao J, Feng Y, Rinaldi E, Saraceno D, Derosa M, Meyers RL. PMID: 32383794.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    7. Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333. J Clin Oncol. 2020 Apr 10; 38(11):1175-1185. Reddy AT, Strother DR, Judkins AR, Burger PC, Pollack IF, Krailo MD, Buxton AB, Williams-Hughes C, Fouladi M, Mahajan A, Merchant TE, Ho B, Mazewski CM, Lewis VA, Gajjar A, Vezina LG, Booth TN, Parsons KW, Poss VL, Zhou T, Biegel JA, Huang A. PMID: 32105509.
      View in: PubMed   Mentions: 2     Fields:    
    8. Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group. Cardiooncology. 2019; 5:15. Kopp LM, Womer RB, Schwartz CL, Ebb DH, Franco VI, Hall D, Barkauskas DA, Krailo MD, Grier HE, Meyers PA, Wexler LH, Marina NM, Janeway KA, Gorlick R, Bernstein ML, Lipshultz SE. PMID: 32154021.
      View in: PubMed   Mentions:
    9. Rejoinder. Clin Trials. 2019 12; 16(6):613-615. Ji L, McShane LM, Krailo M, Sposto R. PMID: 31581812.
      View in: PubMed   Mentions:    Fields:    
    10. Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial. Clin Trials. 2019 12; 16(6):599-609. Ji L, McShane LM, Krailo M, Sposto R. PMID: 31581815.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group. Eur J Cancer. 2019 11; 121:177-183. Kopp LM, Malempati S, Krailo M, Gao Y, Buxton A, Weigel BJ, Hawthorne T, Crowley E, Moscow JA, Reid JM, Villalobos V, Randall RL, Gorlick R, Janeway KA. PMID: 31586757.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    12. Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy. JMIR Res Protoc. 2019 Sep 26; 8(8):e14406. Calaminus G, Jenney M, Hjorth L, Baust K, Bernstein M, Bielack S, Vos P, Hogendoorn PCW, Jovic G, Krailo M, Kreitz K, Marina N, Popoola BO, Sauerland C, Smeland S, Teske C, Schweinitz CV, Whelan J, Wiener A, Sydes MR, Nagarajan R. PMID: 31573951.
      View in: PubMed   Mentions:
    13. Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study. J Clin Oncol. 2019 12 10; 37(35):3369-3376. Rodriguez-Galindo C, Krailo MD, Krasin MJ, Huang L, McCarville MB, Hicks J, Pashankar F, Pappo AS. PMID: 31553639.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. J Clin Oncol. 2019 12 01; 37(34):3192-3202. Dirksen U, Brennan B, Le Deley MC, Cozic N, van den Berg H, Bhadri V, Brichard B, Claude L, Craft A, Amler S, Gaspar N, Gelderblom H, Goldsby R, Gorlick R, Grier HE, Guinbretiere JM, Hauser P, Hjorth L, Janeway K, Juergens H, Judson I, Krailo M, Kruseova J, Kuehne T, Ladenstein R, Lervat C, Lessnick SL, Lewis I, Linassier C, Marec-Berard P, Marina N, Morland B, Pacquement H, Paulussen M, Randall RL, Ranft A, Le Teuff G, Wheatley K, Whelan J, Womer R, Oberlin O, Hawkins DS. PMID: 31553693.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study. J Clin Oncol. 2019 11 01; 37(31):2883-2891. Chévez-Barrios P, Eagle RC, Krailo M, Piao J, Albert DM, Gao Y, Vemuganti G, Ali MJ, Khetan V, Honavar SG, O'Brien J, Leahey AM, Matthay K, Meadows A, Chintagumpala M. PMID: 31539297.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. a-Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium. Cancer. 2019 10 15; 125(20):3649-3656. O'Neill AF, Xia C, Krailo MD, Shaikh F, Pashankar FD, Billmire DF, Olson TA, Amatruda JF, Villaluna D, Huang L, Malogolowkin M, Rodriguez-Galindo C, Frazier AL. PMID: 31355926.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII). Eur J Cancer. 2019 09; 118:49-57. Depani S, Stoneham S, Krailo M, Xia C, Nicholson J. PMID: 31306943.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Improvements to the Escalation with Overdose Control design and a comparison with the restricted Continual Reassessment Method. Pharm Stat. 2019 11; 18(6):659-670. Ji L, Lewinger JP, Krailo M, Groshen S, Conti DV, Asgharzadeh S, Sposto R. PMID: 31237419.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee. J Pediatr Surg. 2020 Apr; 55(4):655-659. Weldon CB, Madenci AL, Tiao GM, Dunn SP, Langham MR, McGahren ED, Ranganathan S, López-Terrada DH, Finegold MJ, Malogolowkin MH, Piao J, Huang L, Krailo MD, Meyers RL, Katzenstein HM. PMID: 31126688.
      View in: PubMed   Mentions: 1     Fields:    
    20. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial. Lancet Oncol. 2019 05; 20(5):719-727. Katzenstein HM, Langham MR, Malogolowkin MH, Krailo MD, Towbin AJ, McCarville MB, Finegold MJ, Ranganathan S, Dunn S, McGahren ED, Tiao GM, O'Neill AF, Qayed M, Furman WL, Xia C, Rodriguez-Galindo C, Meyers RL. PMID: 30975630.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    21. Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. Br J Cancer. 2019 Apr; 120(8):869. Shulman DS, Klega K, Imamovic-Tuco A, Clapp A, Nag A, Thorner AR, Van Allen E, Ha G, Lessnick SL, Gorlick R, Janeway KA, Leavey PJ, Mascarenhas L, London WB, Vo KT, Stegmaier K, Hall D, Krailo MD, Barkauskas DA, DuBois SG, Crompton BD. PMID: 30880335.
      View in: PubMed   Mentions:    Fields:    
    22. A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921). Clin Cancer Res. 2019 06 01; 25(11):3229-3238. Mossé YP, Fox E, Teachey DT, Reid JM, Safgren SL, Carol H, Lock RB, Houghton PJ, Smith MA, Hall D, Barkauskas DA, Krailo M, Voss SD, Berg SL, Blaney SM, Weigel BJ. PMID: 30777875.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCTClinical Trials
    23. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 2019 03; 109:36-50. Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N. PMID: 30685685.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    24. Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children's Oncology Group. J Clin Oncol. 2019 02 10; 37(5):396-402. Fonseca A, Xia C, Lorenzo AJ, Krailo M, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Billmire DF, Rodriguez-Galindo C, Frazier AL, Shaikh F. PMID: 30576269.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2019 02; 66(2):e27524. Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Hingorani P, Collier A, Morris CD, Kolb EA, Doski JJ, Womer RB, Gorlick R, Janeway KA. PMID: 30378256.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    26. Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children's Oncology Group. Br J Cancer. 2018 10; 119(7):864-872. Williams LA, Mills L, Hooten AJ, Langer E, Roesler M, Frazier AL, Krailo M, Nelson HH, Bestrashniy J, Amatruda JF, Poynter JN. PMID: 30287918.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    27. Klinefelter syndrome in males with germ cell tumors: A report from the Children's Oncology Group. Cancer. 2018 10 01; 124(19):3900-3908. Williams LA, Pankratz N, Lane J, Krailo M, Roesler M, Richardson M, Frazier AL, Amatruda JF, Poynter JN. PMID: 30291793.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2019 01; 66(1):e27444. Spraker-Perlman HL, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Doski J, Gorlick R, Janeway KA, Isakoff MS. PMID: 30255612.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. Br J Cancer. 2018 08; 119(5):615-621. Shulman DS, Klega K, Imamovic-Tuco A, Clapp A, Nag A, Thorner AR, Van Allen E, Ha G, Lessnick SL, Gorlick R, Janeway KA, Leavey PJ, Mascarenhas L, London WB, Vo KT, Stegmaier K, Hall D, Krailo MD, Barkauskas DA, DuBois SG, Crompton BD. PMID: 30131550.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    30. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults? Gynecol Oncol. 2018 08; 150(2):253-260. Shah R, Xia C, Krailo M, Amatruda JF, Arul SG, Billmire DF, Brady WE, Covens A, Gershenson DM, Hale JP, Hurteau J, Murray MJ, Nicholson JC, Olson TA, Pashankar F, Rodriguez-Galindo C, Shaikh F, Stark D, Frazier AL, Stoneham S. PMID: 29884437.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium. Eur J Cancer. 2018 07; 98:30-37. Frazier AL, Stoneham S, Rodriguez-Galindo C, Dang H, Xia C, Olson TA, Murray MJ, Amatruda JF, Shaikh F, Pashankar F, Billmire D, Krailo M, Stark D, Brougham MFH, Nicholson JC, Hale JP. PMID: 29859339.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials. Cancer Med. 2018 May 30. Minasian LM, Frazier AL, Sung L, O'Mara A, Kelaghan J, Chang KW, Krailo M, Pollock BH, Reaman G, Freyer DR. PMID: 29846043.
      View in: PubMed   Mentions: 1     Fields:    
    33. Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study. Pediatr Blood Cancer. 2018 08; 65(8):e27111. Pashankar F, Frazier AL, Krailo M, Xia C, Pappo AS, Malogolowkin M, Olson TA, Rodriguez-Galindo C. PMID: 29697191.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    34. Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors. Oncologist. 2018 02; 23(2):272. Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, Nicholson JC, Gershenson D, Frazier AL. PMID: 29449513.
      View in: PubMed   Mentions:    Fields:    
    35. Ovarian Yolk Sac Tumors; Does Age Matter? Int J Gynecol Cancer. 2018 01; 28(1):77-84. Faure Conter C, Xia C, Gershenson D, Hurteau J, Covens A, Pashankar F, Krailo M, Billmire D, Patte C, Fresneau B, Shaikh F, Stoneham S, Nicholson J, Murray M, Frazier AL. PMID: 29194189.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study. Pediatr Blood Cancer. 2018 04; 65(4). Dicken BJ, Billmire DF, Krailo M, Xia C, Shaikh F, Cullen JW, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Rescorla FJ, Egler RA, Ross JH, Rodriguez-Galindo C, Frazier AL. PMID: 29286555.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    37. Family history of cancer in children and adolescents with germ cell tumours: a report from the Children's Oncology Group. Br J Cancer. 2018 01; 118(1):121-126. Poynter JN, Richardson M, Roesler M, Krailo M, Amatruda JF, Frazier AL. PMID: 29065103.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. J Clin Oncol. 2017 Oct 20; 35(30):3465-3473. O'Neill AF, Towbin AJ, Krailo MD, Xia C, Gao Y, McCarville MB, Meyers RL, McGahren ED, Tiao GM, Dunn SP, Langham MR, Weldon CB, Finegold MJ, Ranganathan S, Furman WL, Malogolowkin M, Rodriguez-Galindo C, Katzenstein HM. PMID: 28892430.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1286-1294. Ahmed SK, Randall RL, DuBois SG, Harmsen WS, Krailo M, Marcus KJ, Janeway KA, Geller DS, Sorger JI, Womer RB, Granowetter L, Grier HE, Gorlick RG, Laack NNI. PMID: 28964585.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma. Pediatr Blood Cancer. 2017 Dec; 64(12). Flores RJ, Kelly AJ, Li Y, Chen X, McGee C, Krailo M, Barkauskas DA, Hicks J, Man TK. PMID: 28544777.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Clinical trial enrollment of adolescents and young adults with sarcoma. Cancer. 2017 Sep 15; 123(18):3434-3440. Davis LE, Janeway KA, Weiss AR, Chen YE, Scharschmidt TJ, Krailo M, Glade Bender JL, Kopp LM, Patel SR, Schwartz GK, Horvath LE, Hawkins DS, Chuk MK, Reinke DK, Gorlick RG, Randall RL. PMID: 28493547.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    42. Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology group. Genes Chromosomes Cancer. 2017 07; 56(7):548-558. Marcotte EL, Pankratz N, Amatruda JF, Frazier AL, Krailo M, Davies S, Starr JR, Lau CC, Roesler M, Langer E, Hallstrom C, Hooten AJ, Poynter JN. PMID: 28295819.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children's Oncology Group. J Expo Sci Environ Epidemiol. 2017 07; 27(4):359-364. Janitz AE, Ramachandran G, Tomlinson GE, Krailo M, Richardson M, Spector L. PMID: 28272399.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    44. Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group. J Clin Oncol. 2017 Apr 10; 35(11):1203-1210. Shaikh F, Cullen JW, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Villaluna D, Krailo M, Billmire DF, Rescorla FJ, Egler RA, Dicken BJ, Ross JH, Schlatter M, Rodriguez-Galindo C, Frazier AL. PMID: 28240974.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    45. Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee. Cancer. 2017 Jun 15; 123(12):2360-2367. Katzenstein HM, Furman WL, Malogolowkin MH, Krailo MD, McCarville MB, Towbin AJ, Tiao GM, Finegold MJ, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Rodriguez-Galindo C, Meyers RL. PMID: 28211941.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group. Pediatr Blood Cancer. 2017 Jul; 64(7). Friedman DL, Krailo M, Villaluna D, Gombos D, Langholz B, Jubran R, Shields C, Murphree L, O'Brien J, Kessel S, Rodriguez-Galindo C, Chintagumpala M, Meadows AT. PMID: 28019092.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    47. Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial. Lancet Oncol. 2017 01; 18(1):63-74. Freyer DR, Chen L, Krailo MD, Knight K, Villaluna D, Bliss B, Pollock BH, Ramdas J, Lange B, Van Hoff D, VanSoelen ML, Wiernikowski J, Neuwelt EA, Sung L. PMID: 27914822.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    48. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration. Lancet Oncol. 2017 01; 18(1):122-131. Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P. PMID: 27884679.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    49. Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation. Br J Cancer. 2017 01 03; 116(1):21-27. Treister N, Nieder M, Baggott C, Olson E, Chen L, Dang H, Krailo M, August A, Sung L. PMID: 27875526.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    50. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncol. 2016 Oct; 17(10):1396-1408. Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PCW, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MCG, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS. PMID: 27569442.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    51. A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG. Cancer. 2017 Jan 01; 123(1):144-154. Flores RJ, Kelly AJ, Li Y, Nakka M, Barkauskas DA, Krailo M, Wang LL, Perlaky L, Lau CC, Hicks MJ, Man TK. PMID: 27529817.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    52. Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward. J Clin Oncol. 2016 09 01; 34(25):3031-8. Lagmay JP, Krailo MD, Dang H, Kim A, Hawkins DS, Beaty O, Widemann BC, Zwerdling T, Bomgaars L, Langevin AM, Grier HE, Weigel B, Blaney SM, Gorlick R, Janeway KA. PMID: 27400942.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    53. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2016 10; 63(10):1771-9. Cash T, McIlvaine E, Krailo MD, Lessnick SL, Lawlor ER, Laack N, Sorger J, Marina N, Grier HE, Granowetter L, Womer RB, DuBois SG. PMID: 27297500.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    54. Can Big Data Shed Light on the Origins of Pediatric Cancer? Pediatrics. 2016 06; 137(6). Frazier AL, Krailo M, Poynter J. PMID: 27217479.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    55. Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group Study. Ophthalmology. 2016 08; 123(8):1817-1823. Green AL, Chintagumpala M, Krailo M, Langholz B, Albert D, Eagle R, Cockburn M, Chevez-Barrios P, Rodriguez-Galindo C. PMID: 27262763.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    56. Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group. Ann Surg Oncol. 2016 10; 23(11):3541-3547. Daw NC, Laack NN, McIlvaine EJ, Krailo M, Womer RB, Granowetter L, Grier HE, Marina NM, Bernstein ML, Gebhardt MC, Marcus KJ, Advani SM, Healey JH, Letson GD, Gorlick RG, Randall RL. PMID: 27216741.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer. 2016 10; 63(10):1737-43. Bishop MW, Chang YC, Krailo MD, Meyers PA, Provisor AJ, Schwartz CL, Marina NM, Teot LA, Gebhardt MC, Gorlick R, Janeway KA, Chou AJ. PMID: 27128693.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    58. p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma. Cancer Res. 2016 07 01; 76(13):4002-11. Li Y, Nakka M, Kelly AJ, Lau CC, Krailo M, Barkauskas DA, Hicks JM, Man TK. PMID: 27197201.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    59. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. Neuro Oncol. 2016 10; 18(10):1442-50. Jakacki RI, Cohen KJ, Buxton A, Krailo MD, Burger PC, Rosenblum MK, Brat DJ, Hamilton RL, Eckel SP, Zhou T, Lavey RS, Pollack IF. PMID: 27006176.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    60. Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 07 15; 22(14):3643-50. Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG. PMID: 26861456.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology Group. J Surg Oncol. 2016 Mar; 113(4):351-4. Morris CD, Teot LA, Bernstein ML, Marina N, Krailo MD, Villaluna D, Janeway KA, DuBois SG, Gorlick RG, Randall RL. PMID: 26776342.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer. 2016 Jan; 52:92-101. Czauderna P, Haeberle B, Hiyama E, Rangaswami A, Krailo M, Maibach R, Rinaldi E, Feng Y, Aronson D, Malogolowkin M, Yoshimura K, Leuschner I, Lopez-Terrada D, Hishiki T, Perilongo G, von Schweinitz D, Schmid I, Watanabe K, Derosa M, Meyers R. PMID: 26655560.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    63. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Mar; 63(3):493-8. Mascarenhas L, Felgenhauer JL, Bond MC, Villaluna D, Femino JD, Laack NN, Ranganathan S, Meyer J, Womer RB, Gorlick R, Krailo MD, Marina N. PMID: 26579879.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    64. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer. 2016 Jan 15; 122(2):230-7. Pashankar F, Hale JP, Dang H, Krailo M, Brady WE, Rodriguez-Galindo C, Nicholson JC, Murray MJ, Bilmire DF, Stoneham S, Arul GS, Olson TA, Stark D, Shaikh F, Amatruda JF, Covens A, Gershenson DM, Frazier AL. PMID: 26485622.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    65. Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group Report. Sarcoma. 2015; 2015:927123. Marina N, Granowetter L, Grier HE, Womer RB, Randall RL, Marcus KJ, McIlvaine E, Krailo M. PMID: 26508901.
      View in: PubMed   Mentions:
    66. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Jan; 63(1):54-61. Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE. PMID: 26398490.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    67. Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Feb; 63(2):370-1. Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Gorlick R, Doski JJ, Womer RB, Janeway KA. PMID: 26376351.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    68. Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group. J Immunother. 2015 Sep; 38(7):299-305. Meany HJ, Seibel NL, Krailo M, Villaluna D, Chen Z, Gaynon P, Neglia JP, Park JR, Hutchinson R, Sato JK, Wells RJ, Woods WG, Reaman G. PMID: 26261894.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    69. Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration. J Clin Oncol. 2015 Sep 20; 33(27):3018-28. Olson TA, Murray MJ, Rodriguez-Galindo C, Nicholson JC, Billmire DF, Krailo MD, Dang HM, Amatruda JF, Thornton CM, Arul GS, Stoneham SJ, Pashankar F, Stark D, Shaikh F, Gershenson DM, Covens A, Hurteau J, Stenning SP, Feldman DR, Grimison PS, Huddart RA, Sweeney C, Powles T, Lopes LF, dos Santos Agular S, Chinnaswamy G, Khaleel S, Abouelnaga S, Hale JP, Frazier AL. PMID: 26304902.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    70. Rare Tumors in Children: Progress Through Collaboration. J Clin Oncol. 2015 Sep 20; 33(27):3047-54. Pappo AS, Furman WL, Schultz KA, Ferrari A, Helman L, Krailo MD. PMID: 26304909.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    71. Identification of Discrete Prognostic Groups in Ewing Sarcoma. Pediatr Blood Cancer. 2016 Jan; 63(1):47-53. Karski EE, McIlvaine E, Segal MR, Krailo M, Grier HE, Granowetter L, Womer RB, Meyers PA, Felgenhauer J, Marina N, DuBois SG. PMID: 26257296.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    72. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. J Clin Oncol. 2015 Jul 10; 33(20):2279-87. Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M. PMID: 26033801.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCTClinical Trials
    73. Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Sep; 62(9):1562-6. Kim A, Widemann BC, Krailo M, Jayaprakash N, Fox E, Weigel B, Blaney SM. PMID: 26207356.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    74. A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†. Neuro Oncol. 2015 Aug; 17(8):1132-8. Chintagumpala M, Eckel SP, Krailo M, Morris M, Adesina A, Packer R, Lau C, Gajjar A. PMID: 25854526.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    75. Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group. J Pathol Clin Res. 2015 Apr; 1(2):83-94. Volchenboum SL, Andrade J, Huang L, Barkauskas DA, Krailo M, Womer RB, Ranft A, Potratz J, Dirksen U, Triche TJ, Lawlor ER. PMID: 26052443.
      View in: PubMed   Mentions: 15     Fields:    
    76. Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: Report from the Children's Oncology Group. J Pediatr Surg. 2015 Jun; 50(6):1000-3. Rescorla FJ, Ross JH, Billmire DF, Dicken BJ, Villaluna D, Davis MM, Krailo M, Cullen JW, Olson TA, Egler RA, Amatruda JF, Rodrigues-Galindo C, Frazier AL. PMID: 25812445.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    77. Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status. Epigenetics. 2015; 10(1):31-9. Rosenblum JM, Wijetunga NA, Fazzari MJ, Krailo M, Barkauskas DA, Gorlick R, Greally JM. PMID: 25531418.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    78. Impact of central surgical review in a study of malignant germ cell tumors. J Pediatr Surg. 2015 Sep; 50(9):1502-5. Billmire DF, Rescorla FJ, Ross JH, Schlatter MG, Dicken BJ, Krailo MD, Rodriguez-Galindo C, Olson TA, Cullen JW, Frazier AL. PMID: 25783295.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. A summary of the osteosarcoma banking efforts: a report from the Children's Oncology Group and the QuadW Foundation. Pediatr Blood Cancer. 2015 Mar; 62(3):450-5. Glover J, Krailo M, Tello T, Marina N, Janeway K, Barkauskas D, Fan TM, Gorlick R, Khanna C. PMID: 25611047.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    80. Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 May; 62(5):759-65. Lerman DM, Monument MJ, McIlvaine E, Liu XQ, Huang D, Monovich L, Beeler N, Gorlick RG, Marina NM, Womer RB, Bridge JA, Krailo MD, Randall RL, Lessnick SL. PMID: 25464386.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    81. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States. J Clin Oncol. 2015 Jan 10; 33(2):195-201. Frazier AL, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray MJ, Amatruda JF, Thornton C, Arul GS, Billmire D, Shaikh F, Pashankar F, Stoneham S, Krailo M, Nicholson JC. PMID: 25452439.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    82. Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Mar; 62(3):440-4. Wagner LM, Fouladi M, Ahmed A, Krailo MD, Weigel B, DuBois SG, Doyle LA, Chen H, Blaney SM. PMID: 25446280.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    83. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment. Ann Oncol. 2015 Feb; 26(2):407-14. Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M. PMID: 25421877.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    84. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival. Cancer. 2015 Mar 01; 121(5):697-707. Tilan JU, Krailo M, Barkauskas DA, Galli S, Mtaweh H, Long J, Wang H, Hawkins K, Lu C, Jeha D, Izycka-Swieszewska E, Lawlor ER, Toretsky JA, Kitlinska JB. PMID: 25387699.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    85. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. Cancer. 2015 Feb 01; 121(3):467-75. DuBois SG, Krailo MD, Gebhardt MC, Donaldson SS, Marcus KJ, Dormans J, Shamberger RC, Sailer S, Nicholas RW, Healey JH, Tarbell NJ, Randall RL, Devidas M, Meyer JS, Granowetter L, Womer RB, Bernstein M, Marina N, Grier HE. PMID: 25251206.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    86. Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group. PLoS One. 2014; 9(8):e104378. Monument MJ, Johnson KM, McIlvaine E, Abegglen L, Watkins WS, Jorde LB, Womer RB, Beeler N, Monovich L, Lawlor ER, Bridge JA, Schiffman JD, Krailo MD, Randall RL, Lessnick SL. PMID: 25093581.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    87. Reply to G. Mangili et al and C. Lhommé et al. J Clin Oncol. 2014 Sep 01; 32(25):2816-7. Billmire DF, Krailo M, Rodriguez-Galindo C, Frazier AL. PMID: 25071123.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    88. Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2014 Nov; 61(11):2018-23. Turcotte LM, Georgieff MK, Ross JA, Feusner JH, Tomlinson GE, Malogolowkin MH, Krailo MD, Miller N, Fonstad R, Spector LG. PMID: 25044669.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    89. Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB). Am J Med Genet A. 2014 Sep; 164A(9):2250-5. Venkatramani R, Spector LG, Georgieff M, Tomlinson G, Krailo M, Malogolowkin M, Kohlmann W, Curtin K, Fonstad RK, Schiffman JD. PMID: 24934283.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    90. Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors. Oncologist. 2014 Jul; 19(7):689-92. Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, Nicholson JC, Gershenson D, Frazier AL. PMID: 24899644.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    91. The Children's Oncology Group Childhood Cancer Research Network (CCRN): case catchment in the United States. Cancer. 2014 Oct 01; 120(19):3007-15. Musselman JR, Spector LG, Krailo MD, Reaman GH, Linabery AM, Poynter JN, Stork SK, Adamson PC, Ross JA. PMID: 24889136.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    92. Toward a drug development path that targets metastatic progression in osteosarcoma. Clin Cancer Res. 2014 Aug 15; 20(16):4200-9. Khanna C, Fan TM, Gorlick R, Helman LJ, Kleinerman ES, Adamson PC, Houghton PJ, Tap WD, Welch DR, Steeg PS, Merlino G, Sorensen PH, Meltzer P, Kirsch DG, Janeway KA, Weigel B, Randall L, Withrow SJ, Paoloni M, Kaplan R, Teicher BA, Seibel NL, Smith M, Uren A, Patel SR, Trent J, Savage SA, Mirabello L, Reinke D, Barkaukas DA, Krailo M, Bernstein M. PMID: 24803583.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimals
    93. HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. Pediatr Blood Cancer. 2014 Sep; 61(9):1558-64. Gorlick S, Barkauskas DA, Krailo M, Piperdi S, Sowers R, Gill J, Geller D, Randall RL, Janeway K, Schwartz C, Grier H, Meyers PA, Gorlick R, Bernstein M, Marina N. PMID: 24753182.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    94. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group. J Clin Oncol. 2014 Feb 10; 32(5):465-70. Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, Malogolowkin MH, Pashankar F, Villaluna D, Krailo M, Egler RA, Rodriguez-Galindo C, Frazier AL. PMID: 24395845.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    95. Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study. Pediatr Blood Cancer. 2014 Apr; 61(4):749-52. Borinstein SC, Barkauskas DA, Bernstein M, Goorin A, Gorlick R, Krailo M, Schwartz CL, Wexler LH, Toretsky JA. PMID: 24178953.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    96. Response to "High BMI at diagnosis is associated with inferior survival in patients with osteosarcoma". Pediatr Blood Cancer. 2014 May; 61(5):951. Altaf S, Enders F, Krailo M, Barkauskas D, Meyers P, Arndt C. PMID: 24127421.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    97. Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2014 Mar; 61(3):452-6. Weigel B, Malempati S, Reid JM, Voss SD, Cho SY, Chen HX, Krailo M, Villaluna D, Adamson PC, Blaney SM. PMID: 23956055.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    98. High-BMI at diagnosis is associated with inferior survival in patients with osteosarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2013 Dec; 60(12):2042-6. Altaf S, Enders F, Jeavons E, Krailo M, Barkauskas DA, Meyers P, Arndt C. PMID: 23955975.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    99. Parental tobacco and alcohol use and risk of hepatoblastoma in offspring: a report from the children's oncology group. Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22(10):1837-43. Johnson KJ, Williams KS, Ross JA, Krailo MD, Tomlinson GE, Malogolowkin MH, Feusner JH, Spector LG. PMID: 23950215.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    100. Outcomes for patients with congenital hepatoblastoma. Pediatr Blood Cancer. 2013 Nov; 60(11):1817-25. Trobaugh-Lotrario AD, Chaiyachati BH, Meyers RL, Häberle B, Tomlinson GE, Katzenstein HM, Malogolowkin MH, von Schweinitz D, Krailo M, Feusner JH. PMID: 23798361.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    101. Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG). Pediatr Blood Cancer. 2013 Oct; 60(10):1602-5. Malogolowkin MH, Krailo M, Marina N, Olson T, Frazier AL. PMID: 23703725.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    102. Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group. Eur J Cancer. 2013 Jul; 49(10):2384-91. Goldsby RE, Fan TM, Villaluna D, Wagner LM, Isakoff MS, Meyer J, Randall RL, Lee S, Kim G, Bernstein M, Gorlick R, Krailo M, Marina N. PMID: 23664013.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    103. A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group. Front Oncol. 2013; 3:57. Borinstein SC, Beeler N, Block JJ, Gorlick R, Grohar P, Jedlicka P, Krailo M, Morris C, Phillips S, Siegal GP, Lawlor ER, Lessnick SL. PMID: 23519678.
      View in: PubMed   Mentions:
    104. Maternal pregnancy events and exposures and risk of hepatoblastoma: a Children's Oncology Group (COG) study. Cancer Epidemiol. 2013 Jun; 37(3):318-20. Musselman JR, Georgieff MK, Ross JA, Tomlinson GE, Feusner J, Krailo M, Spector LG. PMID: 23312454.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    105. Children's Oncology Group's 2013 blueprint for research: rare tumors. Pediatr Blood Cancer. 2013 Jun; 60(6):1016-21. Rodriguez-Galindo C, Krailo M, Frazier L, Chintagumpala M, Amatruda J, Katzenstein H, Malogolowkin M, Spector L, Pashankar F, Meyers R, Tomlinson G. PMID: 23255219.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    106. Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children's Oncology Group (COG) study. Int J Mol Epidemiol Genet. 2012; 3(4):286-93. Musselman JR, Bergemann TL, Ross JA, Sklar C, Silverstein KA, Langer EK, Savage SA, Nagarajan R, Krailo M, Malkin D, Spector LG. PMID: 23205180.
      View in: PubMed   Mentions:
    107. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2012 Nov 20; 30(33):4148-54. Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP, Weiss AR. PMID: 23091096.
      View in: PubMed   Mentions: 120     Fields:    Translation:Humans
    108. A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893. Pediatr Blood Cancer. 2013 Mar; 60(3):409-14. Felgenhauer JL, Nieder ML, Krailo MD, Bernstein ML, Henry DW, Malkin D, Baruchel S, Chuba PJ, Sailer SL, Brown K, Ranganathan S, Marina N. PMID: 23065953.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    109. Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2013 Feb; 60(2):237-41. Warwick AB, Malempati S, Krailo M, Melemed A, Gorlick R, Ames MM, Safgren SL, Adamson PC, Blaney SM. PMID: 22745043.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    110. Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. J Clin Oncol. 2012 Jul 10; 30(20):2545-51. Ebb D, Meyers P, Grier H, Bernstein M, Gorlick R, Lipshultz SE, Krailo M, Devidas M, Barkauskas DA, Siegal GP, Ferguson WS, Letson GD, Marcus K, Goorin A, Beardsley P, Marina N. PMID: 22665540.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCTClinical Trials
    111. "Accelerated ear-age": a new measure of chemotherapy-induced ototoxicity. Pediatr Blood Cancer. 2012 Nov; 59(5):947-9. Fligor BJ, Krasker JD, Villaluna D, Krailo M, Frazier AL. PMID: 22492682.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    112. Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology Group. Hum Reprod. 2012 Jun; 27(6):1649-56. Puumala SE, Ross JA, Feusner JH, Tomlinson GE, Malogolowkin MH, Krailo MD, Spector LG. PMID: 22473396.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    113. Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group. Cancer. 2012 Sep 15; 118(18):4597-605. Janeway KA, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Ebb DH, Seibel NL, Grier HE, Gorlick R, Marina N. PMID: 22252521.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    114. Treatment of hepatoblastoma: the North American cooperative group experience. Front Biosci (Elite Ed). 2012 Jan 01; 4:1717-23. Malogolowkin MH, Katzenstein HM, Krailo M, Meyers RL. PMID: 22201987.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    115. Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2012 Jan 20; 30(3):256-62. Malempati S, Weigel B, Ingle AM, Ahern CH, Carroll JM, Roberts CT, Reid JM, Schmechel S, Voss SD, Cho SY, Chen HX, Krailo MD, Adamson PC, Blaney SM. PMID: 22184397.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCTClinical Trials
    116. A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group. Eur J Cancer. 2012 Mar; 48(4):579-85. Baruchel S, Pappo A, Krailo M, Baker KS, Wu B, Villaluna D, Lee-Scott M, Adamson PC, Blaney SM. PMID: 22088484.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    117. Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962). Pediatr Blood Cancer. 2012 Mar; 58(3):362-5. Potter SL, Berg S, Ingle AM, Krailo M, Adamson PC, Blaney SM. PMID: 21910214.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    118. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group. J Clin Oncol. 2011 Aug 20; 29(24):3301-6. Malogolowkin MH, Katzenstein HM, Meyers RL, Krailo MD, Rowland JM, Haas J, Finegold MJ. PMID: 21768450.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    119. Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study. Biol Blood Marrow Transplant. 2012 Jan; 18(1):84-91. Gilman AL, Schultz KR, Goldman FD, Sale GE, Krailo MD, Chen Z, Langholz B, Jacobsohn DA, Chan KW, Ryan RE, Kellick M, Neudorf SM, Godder K, Sandler ES, Sahdev I, Grupp SA, Sanders JE, Wall DA. PMID: 21689773.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    120. Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031. Biol Blood Marrow Transplant. 2011 Dec; 17(12):1804-13. Rozmus J, Schultz KR, Wynne K, Kariminia A, Satyanarayana P, Krailo M, Grupp SA, Gilman AL, Goldman FD. PMID: 21669298.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    121. Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group. Cancer. 2011 Nov 01; 117(21):4966-76. Borinstein SC, Barkauskas DA, Krailo M, Scher D, Scher L, Schlottmann S, Kallakury B, Dickman PS, Pawel BR, West DC, Womer RB, Toretsky JA. PMID: 21480204.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    122. Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011 Dec 01; 57(6):939-42. Hingorani P, Seidel K, Krailo M, Mascarenhas L, Meyers P, Marina N, Conrad EU, Hawkins DS. PMID: 21480474.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    123. The Children's Oncology Group routinely applies "lack of efficacy" interim monitoring to its randomized clinical trials. Am J Bioeth. 2011 Mar; 11(3):18-9. Anderson JR, Krailo M. PMID: 21400379.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    124. Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group. Clin Cancer Res. 2011 Jan 01; 17(1):56-66. Cooper A, van Doorninck J, Ji L, Russell D, Ladanyi M, Shimada H, Krailo M, Womer RB, Hsu JH, Thomas D, Triche TJ, Sposto R, Lawlor ER. PMID: 21047978.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    125. Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans. J Clin Oncol. 2010 Nov 20; 28(33):5011-6. Pappo AS, Krailo M, Chen Z, Rodriguez-Galindo C, Reaman G. PMID: 20956621.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    126. Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Oct; 55(4):629-38. George RE, Lahti JM, Adamson PC, Zhu K, Finkelstein D, Ingle AM, Reid JM, Krailo M, Neuberg D, Blaney SM, Diller L. PMID: 20589651.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    127. A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Sep; 55(3):440-5. Beaty O, Berg S, Blaney S, Malogolowkin M, Krailo M, Knight R, Schaiquevich P, Stewart C, Chen Z, Nelson M, Voss S, Ivy SP, Adamson PC. PMID: 20658614.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    128. Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology Group. Clin Cancer Res. 2010 Aug 01; 16(15):4024-30. Arndt CA, Koshkina NV, Inwards CY, Hawkins DS, Krailo MD, Villaluna D, Anderson PM, Goorin AM, Blakely ML, Bernstein M, Bell SA, Ray K, Grendahl DC, Marina N, Kleinerman ES. PMID: 20576718.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    129. A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trials. Contemp Clin Trials. 2010 Sep; 31(5):473-82. Chen Z, Krailo MD, Azen SP, Tighiouart M. PMID: 20609419.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    130. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2010 Apr 20; 28(12):1989-94. van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche TJ, Sposto R, Womer RB, Lawlor ER. PMID: 20308669.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    131. Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031. Bone Marrow Transplant. 2010 Nov; 45(11):1653-7. Cuvelier GD, Kariminia A, Fujii H, Aslanian S, Wall D, Goldman F, Grupp SA, Dunn SE, Krailo M, Shapiro LH, Gilman A, Schultz KR. PMID: 20190833.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    132. Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. Clin Cancer Res. 2010 Jan 15; 16(2):750-4. Jacobs S, Fox E, Krailo M, Hartley G, Navid F, Wexler L, Blaney SM, Goodwin A, Goodspeed W, Balis FM, Adamson PC, Widemann BC. PMID: 20068084.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    133. Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group. Cancer. 2009 Dec 15; 115(24):5828-35. Katzenstein HM, Chang KW, Krailo M, Chen Z, Finegold MJ, Rowland J, Reynolds M, Pappo A, London WB, Malogolowkin M. PMID: 19813275.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    134. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2009 Dec; 53(6):1016-22. Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH. PMID: 19588519.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    135. Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group. Cancer. 2009 Nov 15; 115(22):5339-48. Chou AJ, Kleinerman ES, Krailo MD, Chen Z, Betcher DL, Healey JH, Conrad EU, Nieder ML, Weiner MA, Wells RJ, Womer RB, Meyers PA. PMID: 19637348.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCTClinical Trials
    136. Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study. Pediatr Blood Cancer. 2009 Oct; 53(4):590-3. Kuttesch JF, Krailo MD, Madden T, Johansen M, Bleyer A. PMID: 19533657.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    137. Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study. Cancer. 2009 Apr 15; 115(8):1765-75. McGregor LM, Spunt SL, Furman WL, Stewart CF, Schaiquevich P, Krailo MD, Speights R, Ivy P, Adamson PC, Blaney SM. PMID: 19170226.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    138. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. J Clin Oncol. 2009 May 20; 27(15):2536-41. Granowetter L, Womer R, Devidas M, Krailo M, Wang C, Bernstein M, Marina N, Leavey P, Gebhardt M, Healey J, Shamberger RC, Goorin A, Miser J, Meyer J, Arndt CA, Sailer S, Marcus K, Perlman E, Dickman P, Grier HE. PMID: 19349548.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCTClinical Trials
    139. Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcoma. J Bone Joint Surg Am. 2009 Mar 01; 91(3):604-12. Imran H, Enders F, Krailo M, Sim F, Okuno S, Hawkins D, Neglia J, Randall RL, Womer R, Mascarenhas L, Arndt CA. PMID: 19255220.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    140. Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2009 Mar; 52(3):324-7. DuBois SG, Krailo MD, Lessnick SL, Smith R, Chen Z, Marina N, Grier HE, Stegmaier K. PMID: 18989890.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    141. International collaboration is feasible in trials for rare conditions: the EURAMOS experience. Cancer Treat Res. 2009; 152:339-53. Marina N, Bielack S, Whelan J, Smeland S, Krailo M, Sydes MR, Butterfass-Bahloul T, Calaminus G, Bernstein M. PMID: 20213400.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    142. Problems identified with phase II stopping rules that employ response and early-progression rates. J Clin Oncol. 2009 Feb 01; 27(4):646-7; author reply 647. Anderson JR, Krailo MD. PMID: 19103727.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    143. Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group. J Clin Oncol. 2009 Jan 01; 27(1):85-91. Gilman AL, Ozkaynak MF, Matthay KK, Krailo M, Yu AL, Gan J, Sternberg A, Hank JA, Seeger R, Reaman GH, Sondel PM. PMID: 19047298.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    144. Range and trend of expected toxicity level (ETL) in standard A + B designs: a report from the Children's Oncology Group. Contemp Clin Trials. 2009 Mar; 30(2):123-8. Chen Z, Krailo MD, Sun J, Azen SP. PMID: 19000782.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    145. Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group. Semin Oncol. 2008 Oct; 35(5):484-93. O'Leary M, Krailo M, Anderson JR, Reaman GH. PMID: 18929147.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    146. Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study. J Clin Oncol. 2008 Oct 20; 26(30):4921-7. Jakacki RI, Hamilton M, Gilbertson RJ, Blaney SM, Tersak J, Krailo MD, Ingle AM, Voss SD, Dancey JE, Adamson PC. PMID: 18794549.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    147. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2008 Sep; 51(3):334-8. Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Brown K, Tarbell N, Bernstein ML, Granowetter L, Gebhardt M, Grier HE. PMID: 18506764.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    148. Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study. Neuro Oncol. 2008 Oct; 10(5):752-8. Bradley KA, Pollack IF, Reid JM, Adamson PC, Ames MM, Vezina G, Blaney S, Ivy P, Zhou T, Krailo M, Reaman G, Mehta MP. PMID: 18715950.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    149. Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study. J Clin Oncol. 2008 Aug 01; 26(22):3756-62. Raetz EA, Cairo MS, Borowitz MJ, Blaney SM, Krailo MD, Leil TA, Reid JM, Goldenberg DM, Wegener WA, Carroll WL, Adamson PC. PMID: 18669463.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    150. Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. J Clin Oncol. 2008 May 10; 26(14):2379-83. Malogolowkin MH, Katzenstein HM, Krailo M, Chen Z, Quinn JJ, Reynolds M, Ortega JA. PMID: 18467729.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    151. A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: a Children's Oncology Group study. Pediatr Blood Cancer. 2008 Apr; 50(4):788-92. Horton TM, Ames MM, Reid JM, Krailo MD, Pendergrass T, Mosher R, Reaman GH, Seibel NL. PMID: 17668866.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    152. Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report. Pediatr Blood Cancer. 2008 Mar; 50(3):533-6. Franklin JL, Seibel NL, Krailo M, Fu C, Adamson PC, Reaman G. PMID: 17668867.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    153. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2008 Feb; 50(2):254-8. Bond M, Bernstein ML, Pappo A, Schultz KR, Krailo M, Blaney SM, Adamson PC. PMID: 17262795.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    154. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. J Clin Oncol. 2008 Feb 01; 26(4):633-8. Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE. PMID: 18235123.
      View in: PubMed   Mentions: 188     Fields:    Translation:Humans
    155. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2008 Jan 20; 26(3):399-405. Glade Bender JL, Adamson PC, Reid JM, Xu L, Baruchel S, Shaked Y, Kerbel RS, Cooney-Qualter EM, Stempak D, Chen HX, Nelson MD, Krailo MD, Ingle AM, Blaney SM, Kandel JJ, Yamashiro DJ. PMID: 18202416.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCTClinical Trials
    156. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Pediatr Blood Cancer. 2007 Dec; 49(7):894-900. Miser JS, Goldsby RE, Chen Z, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore SG, Rausen AR, Vietti TJ, Grier HE. PMID: 17584910.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    157. Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma. J Pediatr Surg. 2007 Dec; 42(12):2050-6. Meyers RL, Katzenstein HM, Krailo M, McGahren ED, Malogolowkin MH. PMID: 18082706.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    158. Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2007 Oct 10; 25(29):4622-7. Bomgaars LR, Bernstein M, Krailo M, Kadota R, Das S, Chen Z, Adamson PC, Blaney SM. PMID: 17925558.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    159. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood. 2008 Mar 15; 111(6):3276-85. Fujii H, Cuvelier G, She K, Aslanian S, Shimizu H, Kariminia A, Krailo M, Chen Z, McMaster R, Bergman A, Goldman F, Grupp SA, Wall DA, Gilman AL, Schultz KR. PMID: 17925486.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    160. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group. Cancer. 2007 Oct 01; 110(7):1542-50. Nicholson HS, Kretschmar CS, Krailo M, Bernstein M, Kadota R, Fort D, Friedman H, Harris MB, Tedeschi-Blok N, Mazewski C, Sato J, Reaman GH. PMID: 17705175.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCTClinical Trials
    161. A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study. Clin Cancer Res. 2007 Sep 15; 13(18 Pt 2):5652s-5660s. Cooney-Qualter E, Krailo M, Angiolillo A, Fawwaz RA, Wiseman G, Harrison L, Kohl V, Adamson PC, Ayello J, vande Ven C, Perkins SL, Cairo MS. PMID: 17875803.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    162. Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors. Pediatr Blood Cancer. 2007 Sep; 49(3):352-7. Jimeno A, Daw NC, Amador ML, Cusatis G, Kulesza P, Krailo M, Ingle AM, Blaney SM, Adamson P, Hidalgo M. PMID: 16425266.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    163. Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group. J Clin Oncol. 2007 May 20; 25(15):2057-62. Schwartz CL, Gorlick R, Teot L, Krailo M, Chen Z, Goorin A, Grier HE, Bernstein ML, Meyers P. PMID: 17513810.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    164. Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group. J Clin Oncol. 2007 Apr 20; 25(12):1505-11. Malempati S, Nicholson HS, Reid JM, Blaney SM, Ingle AM, Krailo M, Stork LC, Melemed AS, McGovern R, Safgren S, Ames MM, Adamson PC. PMID: 17442992.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    165. Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2007 Apr 20; 25(12):1512-8. Rheingold SR, Hogarty MD, Blaney SM, Zwiebel JA, Sauk-Schubert C, Chandula R, Krailo MD, Adamson PC. PMID: 17442993.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    166. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943. Cancer. 2007 Apr 15; 109(8):1646-53. Seibel NL, Krailo M, Chen Z, Healey J, Breitfeld PP, Drachtman R, Greffe B, Nachman J, Nadel H, Sato JK, Meyers PA, Reaman GH. PMID: 17334983.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    167. A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 15; 13(6):1789-93. Weigel BJ, Blaney SM, Reid JM, Safgren SL, Bagatell R, Kersey J, Neglia JP, Ivy SP, Ingle AM, Whitesell L, Gilbertson RJ, Krailo M, Ames M, Adamson PC. PMID: 17363534.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    168. Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2007 Apr; 13(4):386-97. She K, Gilman AL, Aslanian S, Shimizu H, Krailo M, Chen Z, Reid GS, Wall D, Goldman F, Schultz KR. PMID: 17382246.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    169. Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2006 Nov; 47(6):790-4. Hawkins DS, Bradfield S, Whitlock JA, Krailo M, Franklin J, Blaney SM, Adamson PC, Reaman G. PMID: 16435380.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    170. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Blood. 2007 Jan 01; 109(1):46-51. Bhatia S, Krailo MD, Chen Z, Burden L, Askin FB, Dickman PS, Grier HE, Link MP, Meyers PA, Perlman EJ, Rausen AR, Robison LL, Vietti TJ, Miser JS. PMID: 16985182.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    171. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. J Clin Oncol. 2006 Aug 20; 24(24):3838-43. Yock TI, Krailo M, Fryer CJ, Donaldson SS, Miser JS, Chen Z, Bernstein M, Laurie F, Gebhardt MC, Grier HE, Tarbell NJ. PMID: 16921035.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    172. Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report. J Clin Oncol. 2006 Aug 01; 24(22):3678-85. Fouladi M, Furman WL, Chin T, Freeman BB, Dudkin L, Stewart CF, Krailo MD, Speights R, Ingle AM, Houghton PJ, Wright J, Adamson PC, Blaney SM. PMID: 16877737.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsCTClinical Trials
    173. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709). J Clin Oncol. 2006 Jul 20; 24(21):3423-30. Villablanca JG, Krailo MD, Ames MM, Reid JM, Reaman GH, Reynolds CP, Reynolds PC. PMID: 16849757.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCTClinical Trials
    174. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J Clin Oncol. 2006 Jun 20; 24(18):2879-84. Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP. PMID: 16782927.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    175. Expression of LINE-1 p40 protein in pediatric malignant germ cell tumors and its association with clinicopathological parameters: a report from the Children's Oncology Group. Cancer Lett. 2007 Mar 18; 247(2):204-12. Su Y, Davies S, Davis M, Lu H, Giller R, Krailo M, Cai Q, Robison L, Shu XO. PMID: 16759797.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    176. Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors: a report from the Children's Oncology Group. Cancer. 2006 Apr 15; 106(8):1821-8. Zwerdling T, Krailo M, Monteleone P, Byrd R, Sato J, Dunaway R, Seibel N, Chen Z, Strain J, Reaman G. PMID: 16532433.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    177. A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group. Clin Cancer Res. 2006 Mar 15; 12(6):1750-9. Osenga KL, Hank JA, Albertini MR, Gan J, Sternberg AG, Eickhoff J, Seeger RC, Matthay KK, Reynolds CP, Twist C, Krailo M, Adamson PC, Reisfeld RA, Gillies SD, Sondel PM. PMID: 16551859.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    178. In utero exposure to female hormones and germ cell tumors in children. Cancer. 2006 Mar 01; 106(5):1169-77. Shankar S, Davies S, Giller R, Krailo M, Davis M, Gardner K, Cai H, Robison L, Shu XO. PMID: 16421921.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    179. Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): a Children's Oncology Group Report. Pediatr Blood Cancer. 2006 Feb; 46(2):193-7. Angiolillo AL, Whitlock J, Chen Z, Krailo M, Reaman G. PMID: 15929131.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    180. Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group. Clin Cancer Res. 2006 Jan 15; 12(2):516-22. Johansen M, Kuttesch J, Bleyer WA, Krailo M, Ames M, Madden T. PMID: 16428494.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    181. Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group. Cancer Chemother Pharmacol. 2006 Sep; 58(3):343-7. Warren K, Jakacki R, Widemann B, Aikin A, Libucha M, Packer R, Vezina G, Reaman G, Shaw D, Krailo M, Osborne C, Cehelsky J, Caldwell D, Stanwood J, Steinberg SM, Balis FM. PMID: 16408203.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    182. Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2005 Dec 20; 23(36):9179-86. Whitlock JA, Krailo M, Reid JM, Ruben SL, Ames MM, Owen W, Reaman G. PMID: 16361620.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    183. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas. Cancer. 2005 Nov 01; 104(9):1968-74. Packer RJ, Krailo M, Mehta M, Warren K, Allen J, Jakacki R, Villablanca JG, Chiba A, Reaman G. PMID: 16177987.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    184. Parental occupational exposure to pesticides and childhood germ-cell tumors. Am J Epidemiol. 2005 Nov 01; 162(9):858-67. Chen Z, Stewart PA, Davies S, Giller R, Krailo M, Davis M, Robison L, Shu XO. PMID: 16192347.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    185. Environmental exposure to residential pesticides, chemicals, dusts, fumes, and metals, and risk of childhood germ cell tumors. Int J Hyg Environ Health. 2006 Jan; 209(1):31-40. Chen Z, Robison L, Giller R, Krailo M, Davis M, Davies S, Shu XO. PMID: 16373200.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    186. Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas. Cancer. 2005 Sep 15; 104(6):1281-7. Packer RJ, Krailo M, Mehta M, Warren K, Allen J, Jakacki R, Villablanca JG, Chiba A, Reaman G. PMID: 16078267.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    187. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2005 Sep; 45(3):274-80. Ozkaynak MF, Krailo M, Chen Z, Feusner J. PMID: 15806544.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    188. Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2005 Sep 01; 23(25):6172-80. Daw NC, Furman WL, Stewart CF, Iacono LC, Krailo M, Bernstein ML, Dancey JE, Speights RA, Blaney SM, Croop JM, Reaman GH, Adamson PC. PMID: 16135484.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    189. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. J Clin Oncol. 2005 May 20; 23(15):3376-82. Berg SL, Blaney SM, Devidas M, Lampkin TA, Murgo A, Bernstein M, Billett A, Kurtzberg J, Reaman G, Gaynon P, Whitlock J, Krailo M, Harris MB. PMID: 15908649.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCTClinical Trials
    190. Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience. Pediatr Blood Cancer. 2005 Apr; 44(4):338-47. Van Winkle P, Angiolillo A, Krailo M, Cheung YK, Anderson B, Davenport V, Reaman G, Cairo MS. PMID: 15503297.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    191. A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience. Clin Cancer Res. 2005 Apr 01; 11(7):2644-50. Angiolillo AL, Davenport V, Bonilla MA, van de Ven C, Ayello J, Militano O, Miller LL, Krailo M, Reaman G, Cairo MS. PMID: 15814645.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    192. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005 Mar 20; 23(9):2004-11. Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H. PMID: 15774791.
      View in: PubMed   Mentions: 190     Fields:    Translation:HumansCTClinical Trials
    193. Risk of childhood germ cell tumors in association with parental smoking and drinking. Cancer. 2005 Mar 01; 103(5):1064-71. Chen Z, Robison L, Giller R, Krailo M, Davis M, Gardner K, Davies S, Shu XO. PMID: 15685619.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    194. A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):672-7. Lau L, Supko JG, Blaney S, Hershon L, Seibel N, Krailo M, Qu W, Malkin D, Jimeno J, Bernstein M, Baruchel S. PMID: 15701855.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    195. Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015). J Clin Oncol. 2004 Dec 01; 22(23):4804-9. Blaney SM, Bernstein M, Neville K, Ginsberg J, Kitchen B, Horton T, Berg SL, Krailo M, Adamson PC. PMID: 15570082.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    196. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol. 2004 Jul 15; 22(14):2873-6. Miser JS, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE. PMID: 15254055.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    197. Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study. Blood. 2004 Nov 01; 104(9):2655-60. Champagne MA, Capdeville R, Krailo M, Qu W, Peng B, Rosamilia M, Therrien M, Zoellner U, Blaney SM, Bernstein M. PMID: 15231574.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCellsCTClinical Trials
    198. Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors. J Clin Oncol. 2004 Jun 15; 22(12):2445-51. Reid JM, Qu W, Safgren SL, Ames MM, Krailo MD, Seibel NL, Kuttesch J, Holcenberg J. PMID: 15197207.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    199. Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study. J Clin Oncol. 2004 Apr 15; 22(8):1413-9. Aquino VM, Weitman SD, Winick NJ, Blaney S, Furman WL, Kepner JL, Bonate P, Krailo M, Qu W, Bernstein M. PMID: 15084615.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    200. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg. 2003 Oct; 238(4):563-7; discussion 567-8. Shamberger RC, LaQuaglia MP, Gebhardt MC, Neff JR, Tarbell NJ, Marcus KC, Sailer SL, Womer RB, Miser JS, Dickman PS, Perlman EJ, Devidas M, Linda SB, Krailo MD, Grier HE, Granowetter L. PMID: 14530727.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    201. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer. 2003 Apr 15; 97(8):2006-12. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC. PMID: 12673731.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    202. Childhood cancer patients' access to cooperative group cancer programs: a population-based study. Cancer. 2003 Mar 01; 97(5):1339-45. Liu L, Krailo M, Reaman GH, Bernstein L. PMID: 12599243.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansPHPublic Health
    203. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003 Feb 20; 348(8):694-701. Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS. PMID: 12594313.
      View in: PubMed   Mentions: 287     Fields:    Translation:HumansCTClinical Trials
    204. Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples. Clin Cancer Res. 2003 Feb; 9(2):837-44. Yang R, Sowers R, Mazza B, Healey JH, Huvos A, Grier H, Bernstein M, Beardsley GP, Krailo MD, Devidas M, Bertino JR, Meyers PA, Gorlick R. PMID: 12576457.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    205. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. Br J Haematol. 2003 Feb; 120(4):660-70. Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Blok N, Kadin ME, Kjeldsberg CR, Wilson JF, Sanger W, Morris E, Krailo MD, Finlay JL. PMID: 12588354.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    206. A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952. Neuro Oncol. 2003 01; 5(1):8-13. Sanghavi SN, Needle MN, Krailo MD, Geyer JR, Ater J, Mehta MP. PMID: 12626128.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    207. Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group. Leuk Lymphoma. 2002 Oct; 43(10):1945-50. Steinherz PG, Seibel NL, Ames MM, Avramis VI, Krailo MD, Liu-Mares W, Reid JM, Safgren SL, Reaman GH. PMID: 12481889.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    208. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study. J Clin Oncol. 2002 Jun 15; 20(12):2789-97. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC. PMID: 12065555.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    209. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia. 2002 Apr; 16(4):594-600. Cairo MS, Krailo MD, Morse M, Hutchinson RJ, Harris RE, Kjeldsberg CR, Kadin ME, Radel E, Steinherz LJ, Morris E, Finlay JL, Meadows AT. PMID: 11960338.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    210. Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report. Ann Oncol. 2002 Mar; 13(3):460-9. Abu-Ghosh AM, Krailo MD, Goldman SC, Slack RS, Davenport V, Morris E, Laver JH, Reaman GH, Cairo MS. PMID: 11996479.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    211. Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942. J Pediatr Hematol Oncol. 2002 Feb; 24(2):89-93. Wells RJ, Reid JM, Ames MM, Mares WL, Krailo MD, Seibel NL, Mosher R, Reaman GH, Wiersma SR. PMID: 11990712.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    212. Phase I trial of anti-B4-blocked ricin in pediatric patients with leukemia and lymphoma. J Immunother. 2001 Nov-Dec; 24(6):511-6. Dinndorf P, Krailo M, Liu-Mares W, Frierdich S, Sondel P, Reaman G. PMID: 11759074.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    213. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol. 2001 Nov; 37(5):432-41. Sposto R, Meadows AT, Chilcote RR, Steinherz PG, Kjeldsberg C, Kadin ME, Krailo MD, Termuhlen AM, Morse M, Siegel SE. PMID: 11745871.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    214. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol. 2001 Jun 01; 19(11):2812-20. Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS, Baker DL, Davis JH, Gerbing RB, Grovas A, Herzog CE, Lindsley KL, Liu-Mares W, Nachman JB, Sieger L, Wadman J, Gorlick RG. PMID: 11387352.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    215. Phase I study of CI-958 in children and adolescents with recurrent solid tumors. Cancer. 2001 Mar 15; 91(6):1166-9. Arndt CA, Krailo MD, Liu-Mares W, Anderson PM, Reaman GH. PMID: 11267962.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    216. A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities. Clin Cancer Res. 2001 Jan; 7(1):58-67. Bracho F, Krailo MD, Shen V, Bergeron S, Davenport V, Liu-Mares W, Blazar BR, Panoskaltsis-Mortari A, van de Ven C, Secola R, Ames MM, Reid JM, Reaman GH, Cairo MS. PMID: 11205919.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    217. Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report. J Pediatr Hematol Oncol. 2001 Jan; 23(1):30-8. Cairo MS, Shen V, Krailo MD, Bauer M, Miser JS, Sato JK, Blatt J, Blazar BR, Frierdich S, Liu-Mares W, Reaman GH. PMID: 11196267.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    218. The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882). J Pediatr Surg. 2001 Jan; 36(1):12-7. Rescorla F, Billmire D, Stolar C, Vinocur C, Colombani P, Cullen J, Giller R, Cushing B, Lauer S, Davis M, Hawkins E, Shuster J, Krailo M. PMID: 11150431.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    219. Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study. J Clin Oncol. 2000 Dec 15; 18(24):4077-85. Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC. PMID: 11118469.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCTClinical Trials
    220. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol. 2000 Jul; 18(14):2665-75. Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, Haas JE, King DR, Liu-Mares W, Sensel MG, Krailo MD. PMID: 10894865.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCTClinical Trials
    221. A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma. Cancer. 2000 Jun 15; 88(12):2838-44. Fernandez MC, Krailo MD, Gerbing RR, Matthay KK. PMID: 10870069.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    222. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000 Jun; 119(6):1154-61. Shamberger RC, Laquaglia MP, Krailo MD, Miser JS, Pritchard DJ, Gebhardt MC, Healey JH, Tarbell NJ, Fryer CJ, Meyers PA, Grier HE. PMID: 10838532.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    223. Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia. Cancer J Sci Am. 2000 Feb; 6 Suppl 1:S39-44. Sievers EL, Lange BJ, Sondel PM, Krailo MD, Gan J, Tjoa T, Liu-Mares W, Feig SA. PMID: 10685657.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    224. Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group. Clin Cancer Res. 1999 Dec; 5(12):3956-62. Frangoul H, Ames MM, Mosher RB, Reid JM, Krailo MD, Seibel NL, Shaw DW, Steinherz PG, Whitlock JA, Holcenberg JS. PMID: 10632325.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    225. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group. Am J Obstet Gynecol. 1999 Aug; 181(2):353-8. Cushing B, Giller R, Ablin A, Cohen L, Cullen J, Hawkins E, Heifetz SA, Krailo M, Lauer SJ, Marina N, Rao PV, Rescorla F, Vinocur CD, Weetman RM, Castleberry RP. PMID: 10454682.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    226. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J Clin Oncol. 1999 Jul; 17(7):2137-43. Marina NM, Cushing B, Giller R, Cohen L, Lauer SJ, Ablin A, Weetman R, Cullen J, Rogers P, Vinocur C, Stolar C, Rescorla F, Hawkins E, Heifetz S, Rao PV, Krailo M, Castleberry RP. PMID: 10561269.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    227. Chromosome abnormalities of eighty-one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences--a Children's Cancer Group study. Genes Chromosomes Cancer. 1999 Jun; 25(2):134-46. Bussey KJ, Lawce HJ, Olson SB, Arthur DC, Kalousek DK, Krailo M, Giller R, Heifetz S, Womer R, Magenis RE. PMID: 10337997.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    228. Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial. Clin Cancer Res. 1999 Apr; 5(4):733-7. Seibel NL, Blaney SM, O'Brien M, Krailo M, Hutchinson R, Mosher RB, Balis FM, Reaman GH. PMID: 10213206.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    229. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol. 1999 Feb; 17(2):569-77. Smith MA, Rubinstein L, Anderson JR, Arthur D, Catalano PJ, Freidlin B, Heyn R, Khayat A, Krailo M, Land VJ, Miser J, Shuster J, Vena D. PMID: 10080601.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    230. A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer Group. Cancer. 1998 Oct 01; 83(7):1449-60. Cairo MS, Krailo MD, Weinthal JA, Secola R, Bergeron S, van de Ven C, Blazar BR, Garrison L, Reaman GH. PMID: 9762948.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    231. Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group. J Clin Oncol. 1998 Sep; 16(9):3037-43. Nicholson HS, Krailo M, Ames MM, Seibel NL, Reid JM, Liu-Mares W, Vezina LG, Ettinger AG, Reaman GH. PMID: 9738573.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    232. A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors. Cancer. 1998 Aug 15; 83(4):813-6. Arndt CA, Krailo MD, Steinherz L, Scheithauer B, Liu-Mares W, Reaman GH. PMID: 9708950.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    233. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial. J Clin Oncol. 1998 Mar; 16(3):897-906. Hutchinson RJ, Fryer CJ, Davis PC, Nachman J, Krailo MD, O'Brien RT, Collins RD, Whalen T, Reardon D, Trigg ME, Gilchrist GS. PMID: 9508171.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    234. Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group. J Clin Oncol. 1998 Mar; 16(3):914-9. Sievers EL, Lange BJ, Sondel PM, Krailo MD, Gan J, Liu-Mares W, Feig SA. PMID: 9508173.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    235. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clin Cancer Res. 1998 Feb; 4(2):357-60. Blaney SM, Needle MN, Gillespie A, Sato JK, Reaman GH, Berg SL, Adamson PC, Krailo MD, Bleyer WA, Poplack DG, Balis FM. PMID: 9516923.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    236. Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group. Clin Cancer Res. 1998 Jan; 4(1):45-52. Avramis VI, Wiersma S, Krailo MD, Ramilo-Torno LV, Sharpe A, Liu-Mares W, Kowck R, Reaman GH, Sato JK. PMID: 9516951.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    237. Phase I/II study of idarubicin given with continuous infusion fludarabine followed by continuous infusion cytarabine in children with acute leukemia: a report from the Children's Cancer Group. J Clin Oncol. 1997 Aug; 15(8):2780-5. Dinndorf PA, Avramis VI, Wiersma S, Krailo MD, Liu-Mares W, Seibel NL, Sato JK, Mosher RB, Kelleher JF, Reaman GH. PMID: 9256119.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    238. A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer Group. Cancer. 1997 Jul 15; 80(2):311-6. Ettinger LJ, Ivy P, Gaynon PS, Ettinger AG, Liu-Mares W, Krailo MD. PMID: 9217045.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    239. A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer. 1997 Jul 15; 80(2):317-33. Frost JD, Hank JA, Reaman GH, Frierdich S, Seeger RC, Gan J, Anderson PM, Ettinger LJ, Cairo MS, Blazar BR, Krailo MD, Matthay KK, Reisfeld RA, Sondel PM. PMID: 9217046.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimalsCTClinical Trials
    240. Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. J Clin Oncol. 1997 Apr; 15(4):1538-43. Blaney SM, Seibel NL, O'Brien M, Reaman GH, Berg SL, Adamson PC, Poplack DG, Krailo MD, Mosher R, Balis FM. PMID: 9193350.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    241. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group. J Clin Oncol. 1997 Mar; 15(3):1190-7. Van Tornout JM, Buckley JD, Quinn JJ, Feusner JH, Krailo MD, King DR, Hammond GD, Ortega JA. PMID: 9060563.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    242. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol. 1997 Jan; 15(1):76-84. Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES, Kisker CT, Miser JS. PMID: 8996127.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCTClinical Trials
    243. A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study. Invest New Drugs. 1996; 13(4):337-42. Geyer JR, Balis FM, Krailo MD, Heideman R, Broxson E, Sato JK, Poplack D, Bleyer WA. PMID: 8824353.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    244. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. J Clin Oncol. 1995 Jun; 13(6):1368-76. Tubergen DG, Krailo MD, Meadows AT, Rosenstock J, Kadin M, Morse M, King D, Steinherz PG, Kersey JH. PMID: 7751881.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    245. An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Childrens Cancer Group (Canada, United States). Cancer Causes Control. 1995 May; 6(3):187-98. Shu XO, Nesbit ME, Buckley JD, Krailo MD, Robinson LL. PMID: 7612798.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    246. Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin. Clin Rheumatol. 1994 Mar; 13(1):60-9. Prete PE, Zane J, Krailo M, Bulanowski M. PMID: 8187446.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    247. A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group. Cancer. 1994 Feb 15; 73(4):1297-301. Ettinger LJ, Gaynon PS, Krailo MD, Ru N, Baum ES, Siegel SE, Hammond GD. PMID: 8313334.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    248. A phase I study of carboplatin in children with acute leukemia in bone marrow relapse. A report from the Childrens Cancer Group. Cancer. 1993 Aug 01; 72(3):917-22. Ettinger LJ, Krailo MD, Gaynon PS, Hammond GD. PMID: 8334645.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    249. Patterns of enrollment on cooperative group studies. An analysis of trends from the Los Angeles County Cancer Surveillance Program. Cancer. 1993 May 15; 71(10 Suppl):3325-30. Krailo MD, Bernstein L, Sullivan-Halley J, Hammond GD. PMID: 8490876.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    250. Trends in patterns of treatment of childhood cancer in Los Angeles County. Cancer. 1993 May 15; 71(10 Suppl):3222-8. Bernstein L, Sullivan-Halley J, Krailo MD, Hammond GD. PMID: 8490858.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    251. Cancer in adolescents and young adults. Cancer. 1993 May 15; 71(10 Suppl):3206-9. Reaman GH, Bonfiglio J, Krailo M, Tebbi CK, Leikin S, Ettinger R, Zeltzer LK, Nachman JB, Rivera GK, Aboulafia A. PMID: 8490852.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    252. American Cancer Society Workshop on Adolescents and Young Adults with Cancer. Workgroup #4: Clinical research implications. Cancer. 1993 Apr 01; 71(7):2423. Hammond GD, Nixon DW, Nachman JB, Murphy SB, Ho RC, Smith MA, Reaman G, Bernstein L, Krailo M, Young JL. PMID: 8453565.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    253. Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res. 1993 Mar 01; 53(5):1032-6. Blaney SM, Balis FM, Cole DE, Craig C, Reid JM, Ames MM, Krailo M, Reaman G, Hammond D, Poplack DG. PMID: 8439950.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    254. Treatment of pulmonary metastases of initial stage I hepatoblastoma in childhood. Report from the Childrens Cancer Group. Cancer. 1993 Feb 01; 71(3):859-64. Feusner JH, Krailo MD, Haas JE, Campbell JR, Lloyd DA, Ablin AR. PMID: 8381705.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    255. Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies. Cancer Treat Res. 1993; 62:287-91. Miser JS, Krailo M. PMID: 7682089.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    256. Lack of significant activity of 2'-deoxycoformycin alone or in combination with adenine arabinoside in relapsed childhood acute lymphoblastic leukemia. A randomized phase II trial from the Childrens Cancer Study Group. Am J Clin Oncol. 1992 Dec; 15(6):490-3. Miser JS, Roloff J, Blatt J, Reaman GH, Krailo MD, Hammond GD. PMID: 1449110.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    257. Phase II trial of indicine N-oxide in relapsed acute leukemia of childhood. A report from the Childrens Cancer Study Group. Am J Clin Oncol. 1992 Apr; 15(2):135-40. Miser JS, Smithson WA, Krivit W, Hughes CH, Davis D, Krailo MD, Hammond GD. PMID: 1553901.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    258. The role of surgery in abdominal non-Hodgkin's lymphoma: experience from the Childrens Cancer Study Group. J Pediatr Surg. 1992 Feb; 27(2):230-5. LaQuaglia MP, Stolar CJ, Krailo M, Exelby P, Siegel S, Meadows A, Hammond D. PMID: 1564623.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    259. The CCSG prospective study of venous access devices: an analysis of insertions and causes for removal. J Pediatr Surg. 1992 Feb; 27(2):155-63; discussion 163-4. Wiener ES, McGuire P, Stolar CJ, Rich RH, Albo VC, Ablin AR, Betcher DL, Sitarz AL, Buckley JD, Krailo MD. PMID: 1564612.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    260. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group. Med Pediatr Oncol. 1992; 20(4):307-11. Finklestein JZ, Krailo MD, Lenarsky C, Ladisch S, Blair GK, Reynolds CP, Sitarz AL, Hammond GD. PMID: 1608352.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    261. Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study Group. Med Pediatr Oncol. 1992; 20(2):124-9. Feig SA, Krailo MD, Harris RE, Baum E, Holcenberg JS, Kaizer H, Steinherz L, Pendergrass TW, Saunders EF, Warkentin PL. PMID: 1734217.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    262. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. J Clin Oncol. 1991 Dec; 9(12):2167-76. Ortega JA, Krailo MD, Haas JE, King DR, Ablin AR, Quinn JJ, Feusner J, Campbell JR, Lloyd DA, Cherlow J. PMID: 1720452.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    263. Phase II trial of indicine N-oxide in relapsed pediatric solid tumors. A report from the Childrens Cancer Study Group. Invest New Drugs. 1991 Nov; 9(4):339-42. Miser JS, Smithson WA, Krivit W, Hughes C, Davis D, Krailo M, Hammond D. PMID: 1804809.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    264. Results of treatment of malignant germ cell tumors in 93 children: a report from the Childrens Cancer Study Group. J Clin Oncol. 1991 Oct; 9(10):1782-92. Ablin AR, Krailo MD, Ramsay NK, Malogolowkin MH, Isaacs H, Raney RB, Adkins J, Hays DM, Benjamin DR, Grosfeld JL. PMID: 1717667.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    265. Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: a report from the Children's Cancer Study Group. Cancer Res. 1991 Sep 15; 51(18):4871-5. Patel R, Newman EM, Villacorte DG, Sato JK, Reaman GH, Finklestein JZ, Krailo MD, Hammond GD, Holcenberg JS. PMID: 1893377.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    266. The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. J Pediatr Surg. 1991 Sep; 26(9):1074-80; discussion 1080-1. King DR, Ortega J, Campbell J, Haas J, Ablin A, Lloyd D, Newman K, Quinn J, Krailo M, Feusner J. PMID: 1658289.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    267. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med. 1991 Apr; 90(4):427-33. Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, Bernstein-Singer M, Akil B, Espina BM, Krailo M. PMID: 1707230.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    268. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol. 1991 Mar; 145(3):459-64; discussion 464-7. Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Nichols P, Kern W, Sakamoto J, Krailo M, Groshen S. PMID: 1997689.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    269. Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial. Cancer. 1990 Dec 15; 66(12):2465-9. Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD, Hammond GD. PMID: 2249186.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    270. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group. J Clin Oncol. 1990 Dec; 8(12):1971-80. Fryer CJ, Hutchinson RJ, Krailo M, Collins RD, Constine LS, Hays DM, Heller RM, Davis PC, Nachman J, O'Brien RT. PMID: 1700080.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    271. Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients. Cancer Res. 1990 Nov 15; 50(22):7226-31. Avramis VI, Champagne J, Sato J, Krailo M, Ettinger LJ, Poplack DG, Finkelstein J, Reaman G, Hammond GD, Holcenberg JS. PMID: 1699658.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    272. Adjuvant chemotherapy following cystectomy benefits patients with deeply invasive bladder cancer. Semin Urol. 1990 Nov; 8(4):279-84. Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Krailo M, Groshen S. PMID: 2284533.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    273. Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: a Childrens Cancer Study Group report. Cancer Res. 1990 Oct 15; 50(20):6525-8. Reid JM, Pendergrass TW, Krailo MD, Hammond GD, Ames MM. PMID: 2208112.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    274. A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group. J Neurooncol. 1990 Aug; 9(1):69-76. Ettinger LJ, Ru N, Krailo M, Ruccione KS, Krivit W, Hammond GD. PMID: 2213117.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    275. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol. 1990 Feb; 8(2):356-64. Richardson JL, Shelton DR, Krailo M, Levine AM. PMID: 2299375.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    276. Germ cell tumors in infancy and childhood: a 45-year experience. Pediatr Pathol. 1990; 10(1-2):231-41. Malogolowkin MH, Mahour GH, Krailo M, Ortega JA. PMID: 2156245.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    277. A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group. Am J Pediatr Hematol Oncol. 1990; 12(3):301-5. Ettinger LJ, Ru N, Krailo MD, Ruccione KS, Krivit WA, Hammond GD. PMID: 2240475.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    278. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer. 1989 Sep 01; 64(5):1082-95. Haas JE, Muczynski KA, Krailo M, Ablin A, Land V, Vietti TJ, Hammond GD. PMID: 2547506.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    279. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. Am J Med. 1989 Jul; 87(1):57-61. Gill PS, Akil B, Colletti P, Rarick M, Loureiro C, Bernstein-Singer M, Krailo M, Levine AM. PMID: 2472743.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    280. Immature teratomas: identification of patients at risk for malignant recurrence. J Natl Cancer Inst. 1989 Jun 07; 81(11):870-4. Malogolowkin MH, Ortega JA, Krailo M, Gonzalez O, Mahour GH, Landing BH, Siegel SE. PMID: 2470911.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    281. The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group. J Pediatr Surg. 1988 Feb; 23(2):146-51. Makley JT, Krailo M, Ertel IJ, Fryer CJ, Baum ES, Weetman RM, Yunis EJ, Bleyer WA, Hammond GD. PMID: 3422682.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    282. A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group. Am J Pediatr Hematol Oncol. 1988; 10(1):18-22. Ettinger LJ, Krailo M, Ruccione KS, Krivit W, Hammond GD. PMID: 3189713.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    283. Phase I/II study of bisantrene in childhood cancer: a report from the Childrens Cancer Study Group. Med Pediatr Oncol. 1988; 16(5):333-6. Movassaghi N, Krivit WA, Krailo MD, Hammond GD. PMID: 3054454.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    284. Biochemical pharmacology of high dose 1-beta-D-arabinofuranosylcytosine in childhood acute leukemia. Cancer Res. 1987 Dec 15; 47(24 Pt 1):6786-92. Avramis VI, Biener R, Krailo M, Finklestein J, Ettinger L, Willoughby M, Siegel SE, Holcenberg JS. PMID: 3479250.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    285. AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol. 1987 Sep; 5(9):1322-8. Gill PS, Levine AM, Krailo M, Rarick MU, Loureiro C, Deyton L, Meyer P, Rasheed S. PMID: 2442321.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    286. The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. Br J Cancer. 1987 Jun; 55(6):681-5. Bernstein L, Ross RK, Lobo RA, Hanisch R, Krailo MD, Henderson BE. PMID: 3620313.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    287. Chronic effects of fractionated renal irradiation on the pharmacokinetics of intravenous methotrexate. Int J Radiat Oncol Biol Phys. 1987 May; 13(5):759-64. Holcenberg JS, Moulder JE, Karmen BA, Krailo MD, Fish BL, Ring BJ, Adams S. PMID: 3570900.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsPHPublic Health
    288. Use of unequal allocation in survival trials. Stat Med. 1987 Mar; 6(2):119-25. Sposto R, Krailo MD. PMID: 3589241.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    289. Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency syndrome. Cancer. 1987 Feb 15; 59(4):731-8. Burkes RL, Abo W, Levine AM, Linker-Israeli M, Parker JW, Gill PS, Krailo M, Horwitz DA. PMID: 3492262.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    290. Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol. 1987 Feb; 38(2):141-7. Burkes RL, Cohen H, Krailo M, Sinow RM, Carmel R. PMID: 2954848.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    291. A randomized study comparing high-dose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group. Med Pediatr Oncol. 1987; 15(2):69-77. Krailo M, Ertel I, Makley J, Fryer CJ, Baum E, Weetman R, Yunis E, Barnes L, Bleyer WA, Hammond GD. PMID: 3295501.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    292. Fitting models of carcinogenesis to a case-control study of breast cancer. J Chronic Dis. 1987; 40 Suppl 2:181S-189S. Krailo M, Thomas DC, Pike MC. PMID: 3667865.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    293. Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results. Ann Intern Med. 1986 Jul; 105(1):32-7. Levine AM, Gill PS, Cohen J, Hawkins JG, Formenti SC, Aguilar S, Meyer PR, Krailo M, Parker J, Rasheed S. PMID: 2424353.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    294. Serum beta-2 microglobulin levels in homosexual men with AIDS and with persistent, generalized lymphadenopathy. Cancer. 1986 Jun 01; 57(11):2190-2. Burkes RL, Sherrod AE, Stewart ML, Gill PS, Aguilar S, Taylor CR, Krailo MD, Levine AM. PMID: 3008977.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    295. Phase II study of vindesine in the treatment of pediatric patients with solid tumors: a report from the Childrens Cancer Study Group. Cancer Treat Rep. 1986 Jun; 70(6):807-9. Krailo MD, Krivit W, Sather H, Hammond D. PMID: 3524830.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    296. Results of initial lymph node biopsy in homosexual men with generalized lymphadenopathy. J Clin Oncol. 1986 Feb; 4(2):165-9. Levine AM, Meyer PR, Gill PS, Burkes RL, Krailo M, Aguilar S, Parker JW. PMID: 3944603.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    297. Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis. Cancer Invest. 1986; 4(5):379-85. Grunberg SM, Akerley WL, Krailo MD, Johnson KB, Baker CR, Cariffe PA. PMID: 3801953.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    298. A comparison of imaging, clinical, and pathologic aspects of space-occupying lesions within the brain in patients with acquired immune deficiency syndrome. Am J Physiol Imaging. 1986; 1(3):134-41. Gill PS, Graham RA, Boswell W, Meyer P, Krailo M, Levine AM. PMID: 3451758.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    299. Retrovirus and malignant lymphoma in homosexual men. JAMA. 1985 Oct 11; 254(14):1921-5. Levine AM, Gill PS, Meyer PR, Burkes RL, Ross R, Dworsky RD, Krailo M, Parker JW, Lukes RJ, Rasheed S. PMID: 2995692.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    300. Prognostic implications of blast cell morphology in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. Cancer Treat Rep. 1985 Oct; 69(10):1211-21. Miller DR, Krailo M, Bleyer WA, Lukens JN, Siegel SE, Coccia PR, Weiner J, Hammond D. PMID: 3862465.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    301. Do regular ovulatory cycles increase breast cancer risk? Cancer. 1985 Sep 01; 56(5):1206-8. Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. PMID: 4016708.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    302. Limitations of numerical ratios for defining monoclonality of immunoglobulin light chains in B-cell lymphomas. Diagn Immunol. 1985; 3(3):133-8. Samoszuk MK, Krailo M, Yan QH, Lukes RJ, Parker JW. PMID: 3931957.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    303. Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women. Cancer Res. 1984 Jul; 44(7):3106-8. Ross RK, Paganini-Hill A, Krailo MD, Gerkins VR, Henderson BE, Pike MC. PMID: 6722826.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    304. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study. J Clin Oncol. 1984 Jul; 2(7):782-7. Grunberg SM, Gala KV, Lampenfeld M, Jamin D, Johnson K, Cariffe P, Strych D, Krailo M. PMID: 6539812.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    305. Age at natural menopause and breast cancer risk: the effect of errors in recall. Am J Epidemiol. 1984 Jan; 119(1):81-5. Paganini-Hill A, Krailo MD, Pike MC. PMID: 6691338.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    306. Breast cancer and oral contraceptives: reply to critics. Lancet. 1983 Dec 17; 2(8364):1414. Pike MC, Henderson BE, Krailo MD, Duke A, Roy S. PMID: 6140505.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    307. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22; 2(8356):926-30. Pike MC, Henderson BE, Krailo MD, Duke A, Roy S. PMID: 6138501.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    308. 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature. 1983 Jun 30; 303(5920):767-70. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. PMID: 6866078.
      View in: PubMed   Mentions: 169     Fields:    Translation:Humans
    309. Estimation of the distribution of age at natural menopause from prevalence data. Am J Epidemiol. 1983 Mar; 117(3):356-61. Krailo MD, Pike MC. PMID: 6829563.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    Mark's Networks
    Concepts (746)
    Derived automatically from this person's publications.
    _
    Co-Authors (44)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _